Signal Transduction and Targeted Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 81.2 | Q1 | 100.0% | 17.740 | Q1 | 99.9% |
| 2024 | 52.7 | Q1 | 100.0% | 12.135 | Q1 | 99.8% |
| 2023 | 40.8 | Q1 | 98.2% | 8.737 | Q1 | 99.7% |
| 2022 | 39.3 | Q1 | 97.3% | 6.630 | Q1 | 99.5% |
| 2021 | 38.1 | Q1 | 97.2% | 5.157 | Q1 | 99.2% |
| 2020 | — | — | 4.284 | Q1 | 98.8% | |
| 2019 | — | — | 3.755 | Q1 | 98.6% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2095-9907
ISSN
2059-3635
country
GBcoverage
2016-2026